Franco Valle
CIK 1699848 · Chief Financial Officer · last filed 2024-12-02
Franco Valle is a Chief Financial Officer who has filed 20 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing shows the insider was granted $3.0K of BMEA on Dec 2, 2024. Across all open-market trades the lifetime net is −$1.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $50.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$50.3K
2
20
-$1.65M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BMEA | Chief Financial Officer | 42,995 | $1.17 | $50.3K | $173.4K | 12 | 2024-12-02 |
| Eidos Therapeutics, Inc. (EIDX) Delisted | Senior Vice President, Finance | 0 | — | — | -$1.82M | 7 | 2021-01-13 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-12-02 | BMEA | Grant (A) | +495 | $3.0K | EDGAR |
| 2024-06-12 | BMEA | Mixed | +16,957 | $72.2K | EDGAR |
| 2024-01-18 | BMEA | Grant (A) | — | $0 | EDGAR |
| 2023-12-01 | BMEA | Grant (A) | +1,345 | $5.1K | EDGAR |
| 2023-06-02 | BMEA | Grant (A) | +4,273 | $16.2K | EDGAR |
| 2023-01-10 | BMEA | Grant (A) | — | $0 | EDGAR |
| 2022-12-02 | BMEA | Grant (A) | +2,518 | $9.5K | EDGAR |
| 2022-11-14 | BMEA | Buy (P) | +4,100 | $31.3K | EDGAR |
| 2022-06-01 | BMEA | Grant (A) | +3,307 | $15.4K | EDGAR |
| 2022-01-18 | BMEA | Buy (P) | +10,000 | $86.8K | EDGAR |